SpringWorks Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Aug '25 Aug 5, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	774	821	635	845	-	-	Upgrade
Market Cap Growth	7.03%	29.18%	-24.81%	-	-	-	Upgrade
Enterprise Value	934	991	701	605	-	-	Upgrade
Last Close Price	12.66	13.46	10.42	13.87	-	-	Upgrade
PE Ratio	-	-	37.76	85.26	-	-	Upgrade
Forward PE	-	-	41.33	19.43	-	-	Upgrade
PS Ratio	3.97	3.89	4.02	7.13	-	-	Upgrade
PB Ratio	1.37	1.41	1.06	1.49	-	-	Upgrade
P/TBV Ratio	1.38	1.42	1.06	1.49	-	-	Upgrade
P/OCF Ratio	36.22	271.85	-	61.80	-	-	Upgrade
EV/Sales Ratio	4.79	4.69	4.43	5.11	-	-	Upgrade
EV/EBITDA Ratio	15.22	17.63	10.68	23.63	-	-	Upgrade
EV/EBIT Ratio	-	-	26.73	42.44	-	-	Upgrade
Debt / Equity Ratio	0.39	0.37	0.29	0.29	0.46	0.43	Upgrade
Debt / EBITDA Ratio	3.57	3.54	2.53	5.95	3.01	3.31	Upgrade
Debt / FCF Ratio	-	-	-	-	4.65	-	Upgrade
Asset Turnover	0.22	0.23	0.16	0.14	0.24	0.22	Upgrade
Inventory Turnover	22.47	27.56	10.51	12.20	10.54	11.76	Upgrade
Quick Ratio	1.26	1.08	0.68	1.18	4.85	5.80	Upgrade
Current Ratio	1.30	1.30	0.90	1.70	5.20	6.43	Upgrade
Return on Equity (ROE)	-7.88%	-5.08%	2.84%	2.19%	8.06%	10.22%	Upgrade
Return on Assets (ROA)	-2.58%	-1.55%	1.62%	1.09%	4.46%	4.71%	Upgrade
Return on Capital (ROIC)	-2.95%	-1.79%	2.15%	1.45%	5.13%	5.08%	Upgrade
Return on Capital Employed (ROCE)	-	-	3.70%	1.70%	6.90%	6.90%	Upgrade
Earnings Yield	-5.97%	-3.69%	2.65%	1.17%	-	-	Upgrade
FCF Yield	-13.37%	-14.72%	-17.86%	-18.43%	-	-	Upgrade
Buyback Yield / Dilution	1.63%	-	-3.09%	-20.41%	-	-20.74%	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.